← Open Payments lookup

ANI MINASYAN: Open Payments

NPI 1467225169 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,443 in 47 payments from 18 companies in 2025. Trend: 2023 $83 · 2024 $766 · 2025 $1,443

Food & beverage: $1,443
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.10$245
Novartis Pharmaceuticals Corporation7$164
Edwards Lifesciences Corporation1$157
Abbott Laboratories1$156
Regeneron Healthcare Solutions, Inc.3$116
Merck Sharp & Dohme LLC4$104
Kestra Medical Technology Services, Inc.3$93
Bayer Healthcare Pharmaceuticals Inc.3$88
AstraZeneca Pharmaceuticals LP4$70
E.R. Squibb & Sons, L.L.C.3$62

Products named: JARDIANCE, SAPIEN 3 Ultra RESILIA, TRICLIP, LEQVIO, EVKEEZA, Assure WCD, Kerendia, FARXIGA.

Industry payments across CA — which companies pay providers there.